Cytokine networks in the pathogenesis of rheumatoid arthritis

N Kondo, T Kuroda, D Kobayashi - International journal of molecular …, 2021 - mdpi.com
Rheumatoid arthritis (RA) is an autoimmune disease characterized by chronic systemic
inflammation causing progressive joint damage that can lead to lifelong disability. The …

Rheumatoid arthritis: advances in treatment strategies

P Prasad, S Verma, Surbhi, NK Ganguly… - Molecular and cellular …, 2023 - Springer
Rheumatoid arthritis (RA) is characterised by severe joint and bone damage due to
heightened autoimmune response at the articular sites. Worldwide annual incidence and …

Activation of the interleukin-23/interleukin-17 signalling pathway in autoinflammatory and autoimmune uveitis

Z Zhong, G Su, A Kijlstra, P Yang - Progress in retinal and eye research, 2021 - Elsevier
Uveitis is a group of diseases characterized by intraocular inflammation, of which some are
driven by autoinflammatory or autoimmune responses, such as Vogt-Koyanagi-Harada …

Pharmacological and non-pharmacological therapeutic strategies in difficult-to-treat rheumatoid arthritis: a systematic literature review informing the EULAR …

NMT Roodenrijs, A Hamar, M Kedves, G Nagy… - RMD open, 2021 - rmdopen.bmj.com
Objectives To summarise, by a systematic literature review (SLR), the evidence regarding
pharmacological and non-pharmacological therapeutic strategies in difficult-to-treat …

Efficacy and safety of IL-17 inhibitors for the treatment of ankylosing spondylitis: a systematic review and meta-analysis

Y Yin, M Wang, M Liu, E Zhou, T Ren, X Chang… - Arthritis research & …, 2020 - Springer
Objectives To systematically assess the efficacy and safety of IL-17 inhibitors in patients with
active ankylosing spondylitis. Methods A systematic review of the literature was performed …

Interleukin-17A interweaves the skeletal and immune systems

M Tang, L Lu, X Yu - Frontiers in Immunology, 2021 - frontiersin.org
The complex crosstalk between the immune and the skeletal systems plays an
indispensable role in the maintenance of skeletal homeostasis. Various cytokines are …

Pharmacogenomics of monoclonal antibodies for the treatment of rheumatoid arthritis

SH Lim, K Kim, CI Choi - Journal of Personalized Medicine, 2022 - mdpi.com
Precision medicine refers to a highly individualized and personalized approach to patient
care. Pharmacogenomics is the study of how an individual's genomic profile affects their …

Targeting IL-17 and its receptors: A feasible way for natural herbal medicines to modulate fibroblast-like synoviocytes in rheumatoid arthritis

Q Liang, L He, J Wang, D Tang, C Wu… - Biochemical Pharmacology, 2024 - Elsevier
Rheumatoid arthritis (RA) is characterized by processive synovial hyperplasia and abnormal
proliferation of fibroblast-like synoviocytes (FLSs), and can eventually lead to progressive …

Emerging concepts and challenges in rheumatoid arthritis gene therapy

AA Deviatkin, YA Vakulenko, LV Akhmadishina… - Biomedicines, 2020 - mdpi.com
Rheumatoid arthritis (RA) is a systemic inflammatory joint disease affecting about 1% of the
population worldwide. Current treatment approaches do not ensure a cure for every patient …

[PDF][PDF] IL-23/IL-17 axis in the pathogenesis and treatment of systemic lupus erythematosus and rheumatoid arthritis.

AF Izati, KK Wong, CHC Maraina - Malaysian Journal of Pathology, 2020 - mjpath.org.my
Abstract Interleukin-23 (IL-23) and IL-17 are the gatekeepers of CD4+ T helper 17 (Th17)
cells where IL-23 is required for the development and expansion of Th17 cells that …